TITLE

Neurofibromatosis type 2 (NF2): A clinical and molecular review

PUB. DATE
January 2009
SOURCE
Orphanet Journal of Rare Diseases;2009, Vol. 4, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43606292

 

Related Articles

  • Mosaic Generalized Neurofibromatosis 1: Report of Two Cases. Hardin, Jori; Behm, Allan; Haber, Richard M. // Journal of Cutaneous Medicine & Surgery;Jul/Aug2014, Vol. 18 Issue 4, p271 

    Background: We report two cases of mosaic generalized neurofibromatosis 1 (NF1) and review the history of the classification of segmentai neurofibromatosis (SNF; Ricardi type NF-V). Somatic mutations giving rise to limited disease, such as segmentai neurofibromatosis are manifestations of...

  • Advances in diagnosis and treatment of Neurofibromatosis type 1. Zheng Jia-wei; Sun Jian; Zhang Zhi-yuan // Shanghai Journal of Stomatology;Dec2007, Vol. 16, p561 

    Neurofibromatosis type 1 (NF1) is one of the most common neurogenetic diseases affecting adults and children. It is an autosomal dominant disorder, characterized by multiple system damages derived from the abnormal differentiation of the neural crest cells, but its pathogenesis is still unclear....

  • Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Rodriguez, Fausto; Stratakis, Constantine; Evans, D. // Acta Neuropathologica;Mar2012, Vol. 123 Issue 3, p349 

    Neoplasms of the peripheral nerve sheath represent essential clinical manifestations of the syndromes known as the neurofibromatoses. Although involvement of multiple organ systems, including skin, central nervous system, and skeleton, may also be conspicuous, peripheral nerve neoplasia is often...

  • Management of neurofibromatosis.  // Bulletin of the World Health Organization;1994, Vol. 72 Issue 3, p511 

    The article highlights the Second Joint World Health Organization (WHO)/National Neurofibromatosis Foundation (NNFF) Meeting on the Control of Neurofibromatosis (NF) which was held in Vienna, Austria, on June 28, 1992. Leaflets covering the clinical, genetic and management aspects of the two...

  • Molecular diagnosis of Neurofibromatosis Type 1 (NF1): An 18 months experience. Griffiths, Sian; Frayling, I.; Upadhyaya, M. // Journal of Medical Genetics;Sep2005, Vol. 42, pS97 

    Presents an abstract of the article "Molecular Diagnosis of Neurofibromatosis Type 1 (NF1): An 18 Months Experience," by Sian Griffiths, I. Frayling, and M. Upadhyaya.

  • Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion. Pizzuti, Antonio; Bottillo, Irene; Inzana, Francesca; Lanari, Valentina; Buttarelli, Francesca; Torrente, Isabella; Giallonardo, Anna; Luca, Alessandro; Dallapiccola, Bruno // Neurogenetics;Aug2011, Vol. 12 Issue 3, p233 

    We report the detailed clinical presentation and molecular features of a spinal neurofibromatosis familial case where a 40-year-old woman, presenting with multiple bilateral spinal neurofibromas and no other clinical feature of neurofibromatosis type 1 (NF1), inherited a paternal large...

  • Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis. Wright, Emma M. M. Burkitt; Sach, Emma; Sharif, Saba; Quarrell, Oliver; Carroll, Thomas; Whitehouse, Richard W.; Upadhyaya, Meena; Huson, Susan M.; Evans, D Gareth R. // Journal of Medical Genetics;Sep2013, Vol. 50 Issue 9, p606 

    Background Consensus clinical diagnostic criteria for neurofibromatosis type I (NF1) include café-au-lait macules and skinfold freckling. The former are frequently the earliest manifestation of NF1, and as such are of particular significance when assessing young children at risk of the...

  • Neurofibromatosis type 2 diagnosed in the absence of vestibular schwannomas. A case report and guidelines for a screening protocol for children at risk. Janse, Arieke J.; Tan, Wee Fu; Majoie, Charles B. L. M.; Bijlsma, Emilia K. // European Journal of Pediatrics;2001, Vol. 160 Issue 7, p439 

    A 5-year-old girl presented with multiple tumours of the central nervous system. As on the first MRI scan bilateral vestibular schwannomas were not detected due to their small size, she initially did not meet the criteria for neurofibromatosis type 2 (NF2), although her clinical symptoms were...

  • Neurofibromatosis gene cloned. Ponder, B. // Nature;8/23/1990, Vol. 346 Issue 6286, p703 

    Reports on the genetic mapping and cloning of the gene for type-1 (Von Recklinghausen) neurofibromatosis (NF-1) disease. Effect on neural crest tissues; Search for gene; DNA map; NF-1 mutations; Clinical consequences of cloning.

  • Tumour?stroma interactions: The causes of crime. Brooksbank, Cath // Nature Reviews Cancer;Jun2002, Vol. 2 Issue 6, p404 

    Presents findings of a study on hereditary type 1 neurofibromatosis (NF1), previously published in the periodical 'Science' in 2002. Influence of surrounding heterozygous cells on tumor formation; Clinical features of NF1 tumors.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics